Filter
107
Text search:
omicron
Featured
Recommendations
22
New Publications
1
Language
Document type
Guidelines
48
Studies & Reports
17
Fact sheets
13
Strategic & Response Plan
11
Situation Updates
8
Manuals
3
Infographics
2
Videos
2
No document type
2
Training Material
1
Countries / Regions
Brazil
8
Latin America and the Carribbean
7
Africa
4
Global
4
Mozambique
3
Ukraine
3
Philippines
2
South Africa
2
Argentina
2
Liberia
1
Nigeria
1
India
1
South Sudan
1
Germany
1
Syria
1
Chad
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Venezuela
1
Eastern Europe
1
Southern Africa
1
Russia
1
Moldova
1
Authors & Publishers
Publication Years
Category
Countries
37
Key Resources
5
Public Health
2
Capacity Building
1
Annual Report MEDBOX
1
Clinical Guidelines
1
Women & Child Health
1
Toolboxes
COVID-19
84
Conflict
4
Caregiver
3
Planetary Health
3
Health Financing Toolbox
3
Natural Hazards
2
Refugee
2
Mental Health
2
Global Health Education
2
TB
1
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19.
The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID
...
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so
...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re
...
May 5, 2022
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F
...
COVID-19 Situation Update OPS/WHO Argentina: 10 February 2022
Situation report generated by the OPS/WHO representation in Argentina
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
APRIL 2021- JULY 2022
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,
...
This policy brief draws from the latest evidence on the impact of vaccination program start date and vaccine rollout rates on health benefits. The objective is to support policymakers on decisions to procure COVID-19 vaccines and roll out vaccination programmes in countries, especially those
where
...
Countries reported disruptions in all health-care settings. In more than half of countries surveyed, many people are still unable to access care at the primary care and community care levels. Significant disruptions have also been reported in emergency care, particularly concerning given the impact
...
